2:00-2:30 PM ET
Council on Foreign Relations' Thomas J. Bollyky
Plagues and parasites have played a central role in world affairs, shaping the evolution of the modern state, the growth of cities, and the disparate fortunes of national economies. This book tells that story, but it is not about the resurgence of pestilence. It is the story of its decline. For the first time in recorded history, virus, bacteria, and other infectious diseases are not the leading cause of death or disability in any region of the world. People are living longer, and fewer mothers are giving birth to many children in the hopes that some might survive. And yet, the news is not all good. Recent reductions in infectious disease have not been accompanied by the same improvements in income, job opportunities, and governance that occurred with these changes in wealthier countries decades ago. There have also been unintended consequences. In this book, Thomas Bollyky explores the paradox in our fight against infectious disease: the world is getting healthier in ways that should make us worry.
Bollyky interweaves a grand historical narrative about the rise and fall of plagues in human societies with contemporary case studies of the consequences. Bollyky visits Dhaka—one of the most densely populated places on the planet—to show how low-cost health tools helped enable the phenomenon of poor world megacities. He visits China and Kenya to illustrate how dramatic declines in plagues have affected national economies. Bollyky traces the role of infectious disease in the migrations from Ireland before the potato famine and to Europe from Africa and elsewhere today.
Historic health achievements are remaking a world that is both worrisome and full of opportunities. Whether the peril or promise of that progress prevails, Bollyky explains, depends on what we do next.
Read more from Bollyky here:
Thomas J. Bollyky is director of the global health program and senior fellow for global health, economics, and development at the Council on Foreign Relations (CFR). He is also an adjunct professor of law at Georgetown University. Bollyky directed the first CFR-sponsored Independent Task Force devoted to global health, entitled The Emerging Global Health Crisis: Noncommunicable Diseases in Low- and Middle-Income Countries. He is also the author of the book Plagues and the Paradox of Progress: Why the World is Getting Healthier in Worrisome Ways.
Prior to coming to CFR, Bollyky was a fellow at the Center for Global Development and a director at the Office of the U.S. Trade Representative (USTR), where he led the negotiations on medical technology regulation in the U.S.-Republic of Korea Free Trade Agreement and represented USTR in the negotiations with China on the safety of food and drug imports. He was a Fulbright scholar to South Africa, where he worked as a staff attorney at the AIDS Law Project, and an attorney at Debevoise & Plimpton LLP, where he represented clients before the International Court of Justice and the U.S. Supreme Court. Bollyky is a former law clerk to Chief Judge Edward R. Korman and was a health policy analyst at the U.S. Department of Health and Human Services.
Bollyky has testified multiple times before the U.S. Senate and his work has appeared in many publications including the New York Times, Science, and Foreign Affairs. Bollyky has served in a variety of capacities at the National Academy of Medicine, including as co-chair of its workshop on international regulatory harmonization and as a member of committees on strengthening food and drug regulation in developing countries and on the role of science, technology, and innovation in the future of the U.S. Agency for International Development. He has been a consultant to the Bill & Melinda Gates Foundation and a temporary legal advisor to the World Health Organization. In 2013, the World Economic Forum named Bollyky as one of its global leaders under forty.
Bollyky received his BA in biology and history at Columbia University and his JD at Stanford Law School, where he was the president of the Stanford Law & Policy Review. He is a member of the New York and U.S. Supreme Court bars.